Table 2.
Indications for PCI, details of coronary angiography and PCI, CAD characteristics, and in-hospital complications in three groups of patients stratified by BMI.
| Clinical feature | BMI ≥30 kg/m2 n = 699 |
BMI 25.0–29.9 kg/m2 n = 1178 |
BMI <25 kg/m2 n = 548 |
P |
|---|---|---|---|---|
| PCI indication | 0.62 | |||
| STEMI | 195 (27.9) | 360 (30.6) | 170 (31.0) | |
| NSTEACS | 343 (49.1) | 540 (45.8) | 249 (45.4) | |
| Stable coronary syndrome | 161 (23.0) | 278 (23.6) | 129 (23.5) | |
| In-hospital medications | ||||
| Aspirin | 690 (98.7) | 1164 (98.8) | 542 (98.9) | 0.45 |
| Second oral antiplatelet | 684 (97.9) | 1157 (98.2) | 545 (99.5) | 0.06 |
| Thrombolysis | 20 (2.9) | 39 (3.3) | 22 (4.0) | 0.52 |
| GPI | 92 (13.2) | 162 (13.8) | 73 (13.3) | 0.92 |
| Beta blockers | 550 (78.7) | 937 (79.5) | 436 (79.6) | 0.78 |
| RAASB | 457 (65.4) | 723 (61.4) | 322 (58.8) | 0.06 |
| Statins | 680 (97.3) | 1148 (97.5) | 529 (96.5) | 0.49 |
| GRACE risk score | ||||
| On admission | 111.4 ± 34.1 | 115.4 ± 35.7 | 119.8 ± 36.8 | 0.001 |
| Pre-discharge | 71.9 ± 22.1 | 73.3 ± 22.6 | 76.0 ± 24.5 | 0.007 |
| CRUSADE bleeding risk score | 20.5 ± 13.8 | 21.9 ± 13.4 | 25.7 ± 13.9 | <0.001 |
| Coronary artery disease | 0.41 | |||
| One vessel | 419 (59.9) | 690 (58.6) | 308 (56.4) | |
| Multi-vessel | 280 (40.1) | 489 (41.5) | 240 (43.8) | |
| PCI | 0.62 | |||
| One vessel | 510 (73.0) | 850 (72.2) | 380 (69.3) | |
| Multi-vessel | 180 (25.7) | 316 (26.8) | 162 (29.6) | |
| LMCA | 9 (1.3) | 12 (1.0) | 6 (1.1) | |
| In-hospital complications | ||||
| Ventricular tachyarrhythmia | 1 (0.1) | 11 (0.9) | 3 (0.5) | 0.08 |
| Heart failure | 51 (7.3) | 98 (8.3) | 45 (8.2) | 0.72 |
| Cardiogenic shock | 4 (0.6) | 10 (0.8) | 0 (0.0) | 0.10 |
| Emergency CABG | 1 (0.1) | 1 (0.1) | 1 (0.2) | 0.85 |
| Vascular access hematoma | 21 (3.0) | 28 (2.4) | 17 (3.1) | 0.62 |
| Length of stay | 0.96 | |||
| ≤1 day | 216 (30.9) | 361 (30.6) | 170 (31.0) | |
| 2–3 days | 420 (60.1) | 709 (60.2) | 334 (60.9) | |
| >3 days | 63 (9.0) | 108 (9.2) | 44 (8.1) |
Data are presented as mean ± standard deviation or n (%).
CAD: coronary artery disease; BMI: body mass index; CABG: coronary artery bypass graft; CRUSADE: Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines; CVD: cardiovascular disease; GPI: glycoprotein IIb/IIIa inhibitors; GRACE: Global Registry of Acute Coronary Events; LMCA: left main coronary artery; NSTEACS: non-ST-segment elevation acute coronary syndrome; PCI: percutaneous coronary intervention; RAASB: renin angiotensin-aldosterone blockers; STEMI: ST-segment elevation myocardial infarction.